WuXi AppTec Co., Ltd. (WUXIF)
USD 7.12
(0.0%)
USD 7.12
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.78 Billion CNY | 1.17% |
| 2022 | 1.76 Billion CNY | 8.53% |
| 2021 | 1.62 Billion CNY | -43.66% |
| 2020 | 2.88 Billion CNY | -22.87% |
| 2019 | 3.74 Billion CNY | 480.97% |
| 2018 | 644.09 Million CNY | 114.7% |
| 2017 | 300 Million CNY | 14999999900.0% |
| 2016 | 2.00 CNY | 0.0% |
| 2015 | - CNY | -100.0% |
| 2014 | 86.79 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 3.92 Billion CNY | 316.73% |
| 2024 Q3 | 2.91 Billion CNY | 0.65% |
| 2024 Q2 | 4.01 Billion CNY | 1.02% |
| 2023 Q2 | 1.46 Billion CNY | 15.67% |
| 2023 Q1 | 1.26 Billion CNY | -28.34% |
| 2023 FY | 1.78 Billion CNY | 1.17% |
| 2023 Q4 | 1.78 Billion CNY | 24.96% |
| 2023 Q3 | 1.42 Billion CNY | -2.32% |
| 2022 Q3 | 1.88 Billion CNY | 15.31% |
| 2022 Q1 | 1.7 Billion CNY | 4.59% |
| 2022 FY | 1.76 Billion CNY | 8.53% |
| 2022 Q4 | 1.76 Billion CNY | -6.36% |
| 2022 Q2 | 1.63 Billion CNY | -3.9% |
| 2021 Q4 | 1.62 Billion CNY | -12.1% |
| 2021 FY | 1.62 Billion CNY | -43.66% |
| 2021 Q1 | 2.36 Billion CNY | -17.99% |
| 2021 Q2 | 2 Billion CNY | -15.23% |
| 2021 Q3 | 1.84 Billion CNY | -7.81% |
| 2020 Q4 | 2.88 Billion CNY | -3.71% |
| 2020 Q3 | 2.99 Billion CNY | -15.83% |
| 2020 Q2 | 3.56 Billion CNY | -3.49% |
| 2020 Q1 | 3.68 Billion CNY | -1.39% |
| 2020 FY | 2.88 Billion CNY | -22.87% |
| 2019 Q3 | 3.43 Billion CNY | 354.11% |
| 2019 FY | 3.74 Billion CNY | 480.97% |
| 2019 Q4 | 3.74 Billion CNY | 8.94% |
| 2019 Q2 | 756.36 Million CNY | -0.1% |
| 2019 Q1 | 757.12 Million CNY | 17.55% |
| 2018 Q4 | 644.09 Million CNY | 76.46% |
| 2018 FY | 644.09 Million CNY | 114.7% |
| 2018 Q3 | 365 Million CNY | -21.51% |
| 2018 Q2 | 465 Million CNY | -6.06% |
| 2018 Q1 | 495 Million CNY | 65.0% |
| 2017 FY | 300 Million CNY | 14999999900.0% |
| 2017 Q3 | 232.08 Million CNY | 0.0% |
| 2017 Q4 | 300 Million CNY | 29.26% |
| 2017 Q1 | - CNY | 0.0% |
| 2016 FY | 2.00 CNY | 0.0% |
| 2015 FY | - CNY | -100.0% |
| 2014 FY | 86.79 Million CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 6000.00 USD | -29759380.6% |
| Arrayit Corporation | - USD | -Infinity% |
| Atlantic International Corp. | 1.29 Million USD | -137514.61% |
| Biocept, Inc. | 10.37 Million USD | -17110.302% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 51.3 Million USD | -3380.098% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | -2816.39% |
| HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | -326733.314% |
| iMD Companies, Inc. | 1.1 Million USD | -161685.254% |
| IDenta Corp. | 428.17 Thousand USD | -416917.497% |
| Interpace Biosciences, Inc. | 4.24 Million USD | -41982.697% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | - USD | -Infinity% |
| Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 278 Thousand USD | -642190.948% |
| NovelStem International Corp. | 3.32 Million USD | -53607.796% |
| Optigenex Inc. | 4.42 Million USD | -40232.998% |
| PharmChem, Inc. | - USD | -Infinity% |
| Proteome Sciences plc | 1.63 Million USD | -109376.937% |
| Response Genetics, Inc | 4.91 Million USD | -36206.808% |
| Rennova Health, Inc. | 359.19 Thousand USD | -497005.689% |
| RushNet, Inc. | 4.25 Million USD | -41889.781% |
| ScreenPro Security Inc. | 249.05 Thousand USD | -716851.952% |
| Stella Diagnostics Inc. | 798.44 Thousand USD | -223531.907% |
| StageZero Life Sciences Ltd. | 576.38 Thousand USD | -309689.139% |
| Todos Medical Ltd. | 33 Million USD | -5310.651% |